Recombinant EPO antibody (AA 28-162)
Quick Overview for Recombinant EPO antibody (AA 28-162) (ABIN7873231)
Target
See all EPO AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 28-162
-
Purpose
- Recombinant EPO Antibody / Erythropoietin
-
Purification
- Protein A affinity chromatography
-
Immunogen
- A recombinant human partial protein (amino acids 28-162) was used as the immunogen for the recombinant EPO antibody.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal dilution of the recombinant EPO antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the recombinant EPO antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- EPO (Erythropoietin (EPO))
-
Alternative Name
- EPO
-
Target Type
- Hormone
-
Background
- Recognizes a protein of about 37 kDa, which is identified as Erythropoietin (EPO). Erythropoietin is a secreted, glycosylated cytokine hormone composed of four alpha helical bundles. It is the primary factor responsible for regulating erythropoiesis during steady-state conditions and in response to blood loss and hemorrhage in the adult organism. Erythropoietin is synthesized by the kidney and stimulates the proliferation and maturation of bone marrow erythroid precursor cells. The protein is found in the plasma and regulates red cell production by promoting erythroid differentiation and initiating hemoglobin synthesis.
-
UniProt
- P01588
-
Pathways
- JAK-STAT Signaling, Hormone Activity, Negative Regulation of intrinsic apoptotic Signaling, Negative Regulation of Transporter Activity
Target
-